Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Arthritis
Arthritis mutilans.
Arthritis
Arthritis mutilans: a report from the GRAPPA 2012 annual meeting.
Arthritis
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial.
Arthritis
Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting.
Arthritis
Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting.
Arthritis
Distinguishing inflammatory from noninflammatory arthritis, enthesitis, and dactylitis in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
Arthritis
GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.
Arthritis
Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.
Arthritis
Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis
The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting.
Arthritis, Juvenile
Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
Arthritis, Psoriatic
Application of the GRAPPA Psoriatic Arthritis Treatment Recommendations in Clinical Practice.
Arthritis, Psoriatic
Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting.
Arthritis, Psoriatic
Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
Arthritis, Psoriatic
Biomarkers of radiographic progression in psoriatic arthritis: a report from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
Bone formation in psoriatic arthritis: a report from the GRAPPA 2013 Annual Meeting.
Arthritis, Psoriatic
Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
Arthritis, Psoriatic
Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Arthritis, Psoriatic
Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Comparison of disease activity measures in early psoriatic arthritis in usual care.
Arthritis, Psoriatic
Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.
Arthritis, Psoriatic
Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
Arthritis, Psoriatic
Composite measures in psoriatic arthritis: GRAPPA 2008.
Arthritis, Psoriatic
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial.
Arthritis, Psoriatic
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
Arthritis, Psoriatic
Current challenges in the genetics of psoriatic arthritis: a report from the GRAPPA 2009 annual meeting.
Arthritis, Psoriatic
Development and Validation of a Sonographic Enthesitis Instrument in Psoriatic Arthritis: The GRAPPA Diagnostic Ultrasound Enthesitis Tool (DUET) Project.
Arthritis, Psoriatic
Development of a Preliminary Ultrasonographic Enthesitis Score in Psoriatic Arthritis - GRAPPA Ultrasound Working Group.
Arthritis, Psoriatic
Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Distinguishing inflammatory from noninflammatory arthritis, enthesitis, and dactylitis in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
Arthritis, Psoriatic
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Genetics of psoriasis and psoriatic arthritis: update and future direction.
Arthritis, Psoriatic
Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
Arthritis, Psoriatic
GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.
Arthritis, Psoriatic
GRAPPA 2017 Project Report.
Arthritis, Psoriatic
GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
Arthritis, Psoriatic
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.
Arthritis, Psoriatic
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA (2003-2013).
Arthritis, Psoriatic
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.
Arthritis, Psoriatic
Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Arthritis, Psoriatic
Inflammatory spinal disease in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
Arthritis, Psoriatic
International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings.
Arthritis, Psoriatic
Magnetic resonance imaging in psoriatic arthritis -- update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Magnetic Resonance Imaging of Axial and Peripheral Disease in Psoriatic Arthritis: A Report From the 2020 GRAPPA Annual Meeting.
Arthritis, Psoriatic
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.
Arthritis, Psoriatic
Nail Enthesis Ultrasound in Psoriasis and Psoriatic Arthritis: A Report from the 2016 GRAPPA Annual Meeting.
Arthritis, Psoriatic
New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Process and challenges faced.
Arthritis, Psoriatic
New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation.
Arthritis, Psoriatic
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
Arthritis, Psoriatic
Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting.
Arthritis, Psoriatic
Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting.
Arthritis, Psoriatic
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study.
Arthritis, Psoriatic
Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.
Arthritis, Psoriatic
Peripheral spondyloarthritis and psoriatic arthritis; overlaps and distinctions: a report from the GRAPPA 2012 annual meeting.
Arthritis, Psoriatic
Peripheral spondyloarthritis: Concept, diagnosis and treatment.
Arthritis, Psoriatic
Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.
Arthritis, Psoriatic
Presidential Round Table: A Report from the GRAPPA Annual Meeting.
Arthritis, Psoriatic
Proceedings of the GRAPPA 2016 Retreat.
Arthritis, Psoriatic
Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Arthritis, Psoriatic
Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
Arthritis, Psoriatic
Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting.
Arthritis, Psoriatic
Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
Arthritis, Psoriatic
Psoriasis and psoriatic arthritis video project: an update from the 2010 GRAPPA annual meeting.
Arthritis, Psoriatic
Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting.
Arthritis, Psoriatic
Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.
Arthritis, Psoriatic
Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and the role of dermatologists: a report from the GRAPPA 2009 annual meeting.
Arthritis, Psoriatic
Radiographic progression is less in psoriatic arthritis achieving a good response to treatment: data using newer composite indices of disease activity.
Arthritis, Psoriatic
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Arthritis, Psoriatic
Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.
Arthritis, Psoriatic
The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database.
Arthritis, Psoriatic
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Arthritis, Psoriatic
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
Arthritis, Psoriatic
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.
Arthritis, Psoriatic
Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting.
Arthritis, Psoriatic
Treatment strategies for psoriatic arthritis.
Arthritis, Psoriatic
Treatments for Psoriatic Arthritis, a Guide for Patients Written by Fellow Patients: A Report from the GRAPPA 2016 Annual Meeting.
Arthritis, Psoriatic
Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Arthritis, Psoriatic
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting.
Arthritis, Psoriatic
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis.
Brain Injuries, Traumatic
Artifactual microhemorrhage generated by susceptibility weighted image processing.
Brain Neoplasms
Elliptical magnetic resonance spectroscopic imaging with GRAPPA for imaging brain tumors at 3 T.
Breast Neoplasms
Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study.
Cardiovascular Diseases
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting.
Chagas Disease
Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
Colorectal Neoplasms
Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
COVID-19
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.
COVID-19
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting.
Influenza, Human
Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response.
Intracranial Aneurysm
Highly accelerated intracranial 4D flow MRI: evaluation of healthy volunteers and patients with intracranial aneurysms.
Leukemia
Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
Leukemia
Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.
Leukemia
DOT1L complex regulates transcriptional initiation in human erythroleukemic cells.
Leukemia
Identification of phenoxyacetamide derivatives as novel DOT1L inhibitors via docking screening and molecular dynamics simulation.
Leukemia
Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
Leukemia
Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia.
Leukemia
Structural characteristics of coiled-coil regions in AF10-DOT1L and AF10-inhibitory peptide complex.
Leukemia, Myeloid, Acute
Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
Metabolic Syndrome
Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting.
Musculoskeletal Diseases
Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Musculoskeletal Diseases
Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Myocardial Infarction
k-t-Space accelerated myocardial perfusion.
Neoplasms
Accelerated 3D bSSFP imaging for treatment planning on an MRI-guided radiotherapy system.
Neoplasms
Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
Neoplasms
Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-? production by mediating H3K79me2/3 methylation in macrophages.
Ovarian Neoplasms
Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
Ovarian Neoplasms
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis.
Psoriasis
Biomarkers for comorbidities in psoriasis: a report from the grappa 2011 annual meeting.
Psoriasis
Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
Psoriasis
Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
Psoriasis
Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Psoriasis
Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting.
Psoriasis
Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
Psoriasis
Composite measures in psoriatic arthritis: GRAPPA 2008.
Psoriasis
Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting.
Psoriasis
Current and relevant concepts in psoriatic arthritis.
Psoriasis
Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments.
Psoriasis
Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.
Psoriasis
Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Psoriasis
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
Psoriasis
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting.
Psoriasis
Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
Psoriasis
Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Psoriasis
Genetics of psoriasis and psoriatic arthritis: update and future direction.
Psoriasis
Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting.
Psoriasis
GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
Psoriasis
GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.
Psoriasis
GRAPPA 2017 Project Report.
Psoriasis
GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting.
Psoriasis
GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting.
Psoriasis
GRAPPA Trainees Symposium 2010: a report from the GRAPPA 2010 annual meeting.
Psoriasis
GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
Psoriasis
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.
Psoriasis
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2008.
Psoriasis
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA (2003-2013).
Psoriasis
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.
Psoriasis
Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Psoriasis
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
Psoriasis
Magnetic resonance imaging in psoriatic arthritis -- update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting.
Psoriasis
Nail Enthesis Ultrasound in Psoriasis and Psoriatic Arthritis: A Report from the 2016 GRAPPA Annual Meeting.
Psoriasis
New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation.
Psoriasis
Options for Assessing Joints and Entheses in Psoriatic Arthritis by Ultrasonography and Magnetic Resonance Imaging: How to Move Forward.
Psoriasis
Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.
Psoriasis
Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting.
Psoriasis
Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting.
Psoriasis
Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.
Psoriasis
Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting.
Psoriasis
Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.
Psoriasis
Presidential Round Table: A Report from the GRAPPA Annual Meeting.
Psoriasis
Proceedings of the GRAPPA 2016 Retreat.
Psoriasis
Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Psoriasis
Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Psoriasis
Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Psoriasis
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Psoriasis
Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Psoriasis
Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
Psoriasis
Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting.
Psoriasis
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting.
Psoriasis
Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
Psoriasis
Psoriasis and psoriatic arthritis video project: an update from the 2010 GRAPPA annual meeting.
Psoriasis
Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting.
Psoriasis
Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.
Psoriasis
Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting.
Psoriasis
Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting.
Psoriasis
Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.
Psoriasis
Rehabilitation in psoriatic arthritis.
Psoriasis
Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting.
Psoriasis
The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database.
Psoriasis
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Psoriasis
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
Psoriasis
The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting.
Psoriasis
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.
Psoriasis
Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting.
Psoriasis
Treatment strategies for early psoriatic arthritis.
Psoriasis
Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group.
Psoriasis
Update on Biomarkers in Psoriatic Arthritis.
Rheumatic Diseases
GRAPPA at the European League Against Rheumatism (EULAR) 2008.
Spinal Diseases
Inflammatory spinal disease in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Spondylitis
Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting.
Spondylitis
Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting.
Spondylitis
Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Spondylitis
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Spondylitis
The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting.
Spondylitis, Ankylosing
Therapies for axial disease in psoriatic arthritis. A systematic review.
Vascular Diseases
Time-resolved 3D contrast-enhanced MRA with GRAPPA on a 1.5-T system for imaging of craniocervical vascular disease: initial experience.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Zhang, W.; Xia, X.; Jalal, D.I.; Kuncewicz, T.; Xu, W.; Lesage, G.D.; Kone, B.C.
Aldosterone-sensitive repression of ENaCalpha transcription by a histone H3 lysine-79 methyltransferase
Am. J. Physiol. Cell Physiol.
290
C936-C946
2006
Homo sapiens, Mus musculus
brenda
Wood, K.; Tellier, M.; Murphy, S.
DOT1L and H3K79 methylation in transcription and genomic stability
Biomolecules
8
E11
2018
Homo sapiens (Q8TEK3)
brenda
Wong, M.; Tee, A.E.L.; Milazzo, G.; Bell, J.L.; Poulos, R.C.; Atmadibrata, B.; Sun, Y.; Jing, D.; Ho, N.; Ling, D.; Liu, P.Y.; Zhang, X.D.; Huettelmaier, S.; Wong, J.W.H.; Wang, J.; Polly, P.; Perini, G.; Scarlett, C.J.; Liu, T.
The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription
Cancer Res.
77
2522-2533
2017
Homo sapiens (Q8TEK3)
brenda
Kuntimaddi, A.; Achille, N.J.; Thorpe, J.; Lokken, A.A.; Singh, R.; Hemenway, C.S.; Adli, M.; Zeleznik-Le, N.J.; Bushweller, J.H.
Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 di- and tri-methylation on target genes and transformation potential
Cell Rep.
11
808-820
2015
Homo sapiens (Q8TEK3), Homo sapiens
brenda
Kari, V.; Raul, S.K.; Henck, J.M.; Kitz, J.; Kramer, F.; Kosinsky, R.L.; Uebelmesser, N.; Mansour, W.Y.; Eggert, J.; Spitzner, M.; Najafova, Z.; Bastians, H.; Grade, M.; Gaedcke, J.; Wegwitz, F.; Johnsen, S.A.
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness
Clin. Epigenetics
11
4-4
2019
Homo sapiens (Q8TEK3)
brenda
Evanno, E.; Godet, J.; Piccirilli, N.; Guilhot, J.; Milin, S.; Gombert, J.; Fouchaq, B.; Roche, J.
Tri-methylation of H3K79 is decreased in TGF-beta1-induced epithelial-to-mesenchymal transition in lung cancer
Clin. Epigenetics
9
80
2017
Homo sapiens (Q8TEK3)
brenda
Jang, S.; Kang, C.; Yang, H.S.; Jung, T.; Hebert, H.; Chung, K.Y.; Kim, S.J.; Hohng, S.; Song, J.J.
Structural basis of recognition and destabilization of the histone H2B ubiquitinated nucleosome by the DOT1L histone H3 Lys79 methyltransferase
Genes Dev.
33
620-625
2019
Homo sapiens (Q8TEK3)
brenda
Li, T.; Liu, Q.; Garza, N.; Kornblau, S.; Jin, V.
Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing
Genome Med.
10
30
2018
Homo sapiens (Q8TEK3)
brenda
Valencia-Sanchez, M.I.; De Ioannes, P.; Wang, M.; Vasilyev, N.; Chen, R.; Nudler, E.; Armache, J.P.; Armache, K.J.
Structural basis of Dot1L stimulation by histone H2B lysine 120 ubiquitination
Mol. Cell
74
1010-1019
2019
Homo sapiens (Q8TEK3)
brenda
Farooq, Z.; Banday, S.; Pandita, T.; Altaf, M.
The many faces of histone H3K79 methylation
Mutat. Res. Rev. Mutat. Res.
768
46-52
2016
Saccharomyces cerevisiae (Q04089), Homo sapiens (Q8TEK3)
brenda
Liu, D.; Zhang, X.X.; Li, M.C.; Cao, C.H.; Wan, D.Y.; Xi, B.X.; Tan, J.H.; Wang, J.; Yang, Z.Y.; Feng, X.X.; Ye, F.; Chen, G.; Wu, P.; Xi, L.; Wang, H.; Zhou, J.F.; Feng, Z.H.; Ma, D.; Gao, Q.L.
C/EBPbeta enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Nat. Commun.
9
1739
2018
Homo sapiens (Q8TEK3)
brenda